@article{24de402d3841476d8a10b6f7d70deed3,
title = "Rate control drugs differ in the prevention of progression of atrial fibrillation",
keywords = "Atrial fibrillation, Atrial fibrillation progression, Rate control, Rhythm control, RACE 4 study, VERAPAMIL, TACHYCARDIA, ARRHYTHMOGENESIS, CARDIOVERSION, DIGOXIN, RISK",
author = "T. Koldenhof and P.E.P.J. Wijtvliet and N.A.H.A. Pluymaekers and M. Rienstra and R.J. Folkeringa and P. Bronzwaer and A. Elvan and J. Elders and R. Tukkie and J.G.L.M. Luermans and {van Kuijk}, S.M.J. and J.G.P. Tijssen and {van Gelder}, I.C. and H.J.G.M. Crijns and R.G. Tieleman",
year = "2022",
month = mar,
day = "2",
doi = "10.1093/europace/euab191",
language = "English",
volume = "24",
pages = "384--389",
journal = "EP Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "3",
}